Hodges Capital Management Inc. boosted its stake in Nuvectra Corporation (NASDAQ:NVTR) by 18.6% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 227,807 shares of the company’s stock after buying an additional 35,706 shares during the period. Hodges Capital Management Inc.’s holdings in Nuvectra Corporation were worth $3,025,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently bought and sold shares of the company. Gilder Gagnon Howe & Co. LLC raised its stake in Nuvectra Corporation by 4.2% in the first quarter. Gilder Gagnon Howe & Co. LLC now owns 847,851 shares of the company’s stock valued at $5,791,000 after buying an additional 33,796 shares during the period. Essex Investment Management Co. LLC raised its position in shares of Nuvectra Corporation by 42.1% in the second quarter. Essex Investment Management Co. LLC now owns 202,623 shares of the company’s stock valued at $2,691,000 after buying an additional 60,034 shares during the last quarter. Wells Fargo & Company MN raised its position in shares of Nuvectra Corporation by 0.7% in the first quarter. Wells Fargo & Company MN now owns 112,997 shares of the company’s stock valued at $772,000 after buying an additional 751 shares during the last quarter. Rockefeller Financial Services Inc. raised its position in shares of Nuvectra Corporation by 3.2% in the second quarter. Rockefeller Financial Services Inc. now owns 107,523 shares of the company’s stock valued at $1,428,000 after buying an additional 3,338 shares during the last quarter. Finally, Granite Investment Partners LLC bought a new position in shares of Nuvectra Corporation during the first quarter valued at $702,000. 59.91% of the stock is currently owned by hedge funds and other institutional investors.

Shares of Nuvectra Corporation (NASDAQ:NVTR) opened at 12.03 on Wednesday. The stock’s 50 day moving average is $12.60 and its 200 day moving average is $9.03. The firm’s market cap is $124.41 million. Nuvectra Corporation has a 12 month low of $4.63 and a 12 month high of $15.00.

Nuvectra Corporation (NASDAQ:NVTR) last posted its quarterly earnings data on Tuesday, August 8th. The company reported ($1.07) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($1.14) by $0.07. The business had revenue of $7.20 million during the quarter, compared to the consensus estimate of $5.96 million. Nuvectra Corporation had a negative return on equity of 47.33% and a negative net margin of 286.26%. The firm’s quarterly revenue was up 188.0% compared to the same quarter last year. During the same quarter in the prior year, the company earned ($0.85) earnings per share. Equities research analysts expect that Nuvectra Corporation will post ($4.87) EPS for the current year.

ILLEGAL ACTIVITY NOTICE: This news story was posted by Daily Political and is the sole property of of Daily Political. If you are reading this news story on another publication, it was illegally copied and reposted in violation of U.S. and international copyright and trademark law. The legal version of this news story can be read at https://www.dailypolitical.com/2017/08/09/hodges-capital-management-inc-has-3-03-million-stake-in-nuvectra-corporation-nasdaqnvtr.html.

NVTR has been the topic of several research reports. Zacks Investment Research downgraded shares of Nuvectra Corporation from a “hold” rating to a “sell” rating in a research note on Saturday, May 13th. ValuEngine upgraded shares of Nuvectra Corporation from a “sell” rating to a “hold” rating in a research note on Friday, June 16th. TheStreet raised shares of Nuvectra Corporation from a “d” rating to a “c-” rating in a report on Monday, June 19th. Piper Jaffray Companies reissued a “neutral” rating and issued a $14.00 target price on shares of Nuvectra Corporation in a report on Thursday, July 6th. Finally, B. Riley reissued a “buy” rating and issued a $12.00 target price on shares of Nuvectra Corporation in a report on Monday, May 15th. Three research analysts have rated the stock with a hold rating and one has given a buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $10.50.

In other Nuvectra Corporation news, CEO Scott F. Drees acquired 7,395 shares of the company’s stock in a transaction that occurred on Tuesday, May 30th. The shares were bought at an average cost of $10.41 per share, with a total value of $76,981.95. Following the completion of the transaction, the chief executive officer now directly owns 99,136 shares of the company’s stock, valued at approximately $1,032,005.76. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Scott F. Drees acquired 2,605 shares of the company’s stock in a transaction that occurred on Thursday, May 25th. The shares were acquired at an average cost of $9.92 per share, for a total transaction of $25,841.60. Following the completion of the transaction, the chief executive officer now directly owns 90,041 shares of the company’s stock, valued at $893,206.72. The disclosure for this purchase can be found here.

About Nuvectra Corporation

Nuvectra Corporation is a neurostimulation company that focuses on helping physicians to improve the lives of people with chronic neurological conditions. The Company’s Algovita Spinal Cord Stimulation (SCS) System (Algovita) is the Company’s commercial offering and is Conformite Europeene (CE) marked and the United States Food and Drug Administration (FDA) approved for the treatment of chronic pain of the trunk and/or limbs.

Want to see what other hedge funds are holding NVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nuvectra Corporation (NASDAQ:NVTR).

Institutional Ownership by Quarter for Nuvectra Corporation (NASDAQ:NVTR)

Receive News & Ratings for Nuvectra Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuvectra Corporation and related companies with MarketBeat.com's FREE daily email newsletter.